Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071831 · ClinicalTrials.gov registry record
RETRO Study (RETrograde Renal Access Outcomes)
A clinical trial of Renal Stones, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT07071831 is a study of Renal Stones that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 150 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07071831, a study of Renal Stones, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous nephrolithotomy as part of their regular care will be asked to participate.
Conditions Studied
Interventions
- DEVICE RetroPerc®
Study Locations (2)
Florida
- University of South Florida - Tampa
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07071831
The ClinicalTrials.gov registry entry for NCT07071831 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Renal Stones appearing as the primary indexed condition, and to 1 intervention - of which RetroPerc® is the first listed.
NCT07071831 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT07071831 about?
NCT07071831 is a clinical study titled "RETRO Study (RETrograde Renal Access Outcomes)". The goal of this observational study is to learn about the benefit of using RetroPerc® in obtaining renal access for percutaneous nephrolithotomy. The device is already used in routine clinical practice by urologists around the country. Participants who are already scheduled to undergo percutaneous...
What is the current status of trial NCT07071831?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-12-06. Estimated completion is 2026-12.
What conditions does trial NCT07071831 study?
This clinical trial studies the following conditions: Renal Stones.
What interventions are being tested in trial NCT07071831?
The interventions under investigation include: RetroPerc® (DEVICE).
Who is sponsoring clinical trial NCT07071831?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07071831 being conducted?
This trial has 2 study locations across Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.